// App-Quantinova.ai

P018 : Complete metabonomic and microbiota profiling identifies biomarkers for anti-TNF therapy response

Researchers

Presenter

  • N.S. Ding

Principal Investigators

  • M. Sarafian

  • A. Perdones-Montero

  • R. Misra

  • P. Hendy

  • L. Penez

  • E. Holmes

  • A. Hart

Medical Centers

  • St Vincent's Hospital, Inflammatory Bowel Disease, Melbourne, Australia

  • St Mark's Hospital, Inflammatory Bowel Disease Unit, London, United Kingdom

  • Imperial College London, Department of Surgery and Cancer, London, United Kingdom

  • Guy's Hospital, London, United Kingdom

  • Imperial College London, Department of Surgery and Cancer, London, United Kingdom

Locations

  • Australia

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • C reactive protein

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A